Compound repurposing

Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.

Show/Hide Filters

Items 11-20 of 36

Set Descending Direction
  1. Pack:
    100mg
    Price:
    $33
    Qty:
    Pack:
    1g
    Price:
    $90
    Qty:
  2. Pack:
    50mg
    Price:
    $69
    Qty:
    Pack:
    250mg
    Price:
    $209
    Qty:
  3. Pack:
    25mg
    Price:
    $169
    Qty:
    Pack:
    100mg
    Price:
    $502
    Qty:
  4. Pack:
    10mg
    Price:
    $39
    Qty:
    Pack:
    50mg
    Price:
    $143
    Qty:
  5. FK 506 (HB0289)

    Description:

    Potent calcineurin phosphatase 2B inhibitor. Enhances osteoblastic differentiation in mesenchymal cells.

    Purity:

    >99%

    Pack:
    10mg
    Price:
    $118
    Free trial
    Qty:
    Pack:
    50mg
    Price:
    $494
    Qty:
  6. Description:

    Sphingosine 1-phosphate (S1P) receptor (S1P1, S1P3, S1P4, and S1P5) modulator

    Purity:

    >98%

    Pack:
    25mg
    Price:
    $276
    Qty:
  7. Pack:
    10mg
    Price:
    $41
    Qty:
    Pack:
    50mg
    Price:
    $145
    Qty:
  8. Pack:
    100mg
    Price:
    $87
    Qty:
  9. Description:

    Tyrosine kinase inhibitor that targets BCR‑ABL, c‑KIT, and PDGFR kinases

    Purity:

    >98%

    Pack:
    100mg
    Price:
    $86
    Qty:
Page